Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
MedAdvisor Limited ( (AU:AHE) ) has shared an announcement.
Adheris Health Limited has disclosed a change in director Lucas Merrow’s holdings, with the executive increasing his direct interest in the company through on-market share purchases. Between 4 and 9 March 2026, Merrow acquired 695,000 fully paid ordinary shares at an average price of $0.02175, lifting his total holding to 3,025,290 shares while retaining 1,250,000 unlisted options.
The transactions, which did not occur during a closed trading period, signal increased personal financial commitment by the director to Adheris Health’s equity. This move may be interpreted by investors as a show of confidence in the company’s prospects, though no new contracts or changes in derivative interests were reported alongside the share acquisitions.
The most recent analyst rating on (AU:AHE) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited, formerly known as MedAdvisor Limited, operates in the healthcare and health technology sector. The company is involved in providing health-related services and solutions, likely focused on patient engagement, medication adherence, or similar pharmaceutical support offerings in its markets.
Average Trading Volume: 576,473
Technical Sentiment Signal: Sell
Current Market Cap: A$14.01M
For detailed information about AHE stock, go to TipRanks’ Stock Analysis page.